Diagnosis and Treatment of Childhood Mature B-acute Lymphoblastic Leukaemia inthe Czech Republic in 1990 –2000
Authors:
J. Starý 1; P. Gajdoš 2; O. Hrušák 3; D. Pospíšilová 4; J. Hak 5; L. Kopečná 6; K. Michalová 7
Authors‘ workplace:
II. dětská klinika UK 2. LF a FN Motol, Praha, 2 Státní zdravotní ústav, Praha, 3 Imunologický ústav UK 2. LF a FN Motol, Praha, 4 Dětská klinika FN Olomouc, 5 Dětská klinika FN Hradec Králové, 6 I. dětská interní a onkologická klinika FN Brno, 7 Centrum
1
Published in:
Transfuze Hematol. dnes,, 2002, No. 2, p. 55-58.
Category:
Overview
Acute lymphoblastic leukaemia (ALL)derived from mature B-cells is in fact generalized Burkitt ´slymphoma.Leukemic blasts are classified as L3 according to the FAB morphological classification.Theyare characterized by the presence of the surface immunoglobulins,most often IgM,and by a highproliferative rate.Current treatment comprising short blocks of intensive chemotherapy improvedremarkably the prognosis of this rare disease.Between VI/1990-XII/2000,ALL was diagnosed in 671children and adolescents aged 0 –18 years in the Czech Republic.B-ALL was found in 9 children (1.3 %).Complete remission was achieved in 77.8 %children.Four patients (44.4 %)suffered from early renalfailure which developed as a result of the tumour lysis syndrome.Neither death in remission nor relapsewere seen in this small group of patients.With a median follow-up of 3,7 years,the probability ofevent-free-survival is 75 %(SE 15 %).Therapeutic results of B-ALLin the Czech Republic are comparableto the results of the leading leukaemic study groups in the world.
Key words:
acute lymphoblastic leukaemia,mature-B-cells,treatment,children
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2002 Issue 2
Most read in this issue
- Albumin – to be or not to be ((infused)?
- Lymphoblastic Leukaemia in Infants
- Diagnosis and Treatment of Childhood Mature B-acute Lymphoblastic Leukaemia inthe Czech Republic in 1990 –2000
- International Consensus on the Definition of Invasive Mycotic InfectionsPatients with Malignant Mycotic Infections in Patients with Malignant Diseases andafter Transplantation of Haematopoietic Cells